BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sunho Biologics readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Sunho Biologics's drugs run\, fro
 m ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06581419-2529@assetmemo.bio
DTSTAMP:20261121T010206Z
DTSTART;VALUE=DATE:20290801
DTEND;VALUE=DATE:20290802
SUMMARY:IAP0971: Phase 1/2 readout est. (NCT06581419)
DESCRIPTION:IAP0971\, phase 1/2\, Non-Small Cell Lung Cancer.\nStudy: A Cli
 nical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malign
 ant Tumors\nEstimated primary completion: 1 August 2029. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/iap0971#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT06581419
URL:https://assetmemo.bio/drug/iap0971#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
